Максиколд Лор

Quick links to important sections

Максиколд Лор

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Максиколд Лор

Максиколд Лор

Максиколд Лор is a medicinal preparation intended for topical antiseptic treatment of the oral cavity and pharynx, aimed at reducing local microbial populations. It is formally classified under the Anatomical Therapeutic Chemical (ATC) system as an Antiinfective and Antiseptic for Local Oral Treatment. The medicine is a synthetic single-active-ingredient compound, focused on achieving surface-level anti-microbial action.

Property Description
Active ingredient Hexetidine (INN)
Form Oromucosal Spray or Oral Solution
Pharmacological class Antiseptic / Local Antiinfective Agent
Common use Local anti-microbial action and oral hygiene
Origin Synthetic small molecule drug

Composition, Core Ingredient, and Form

The active component in this preparation is Hexetidine, a synthetic organonitrogen compound confirmed to possess anti-microbial properties. The formulation is often positioned for adult and pediatric use (subject to specific age guidelines) and utilizes a liquid dosage form, commonly a spray or an oral solution for gargling. This liquid delivery ensures the topical application effectively reaches and coats the mucosal surfaces of the pharynx and oral cavity, where the Hexetidine is carried in an aqueous or aqueous-alcoholic vehicle.

General Anti-Microbial Function

The primary function of Максиколд Лор is to exert a broad-spectrum anti-microbial effect directly on the tissue surfaces of the throat and mouth. Hexetidine acts as both a bactericidal (effective against bacteria) and fungicidal agent by interfering with the vital metabolic processes of a wide range of oral pathogens. Pharmacological evidence indicates that its use contributes to reducing bacterial and fungal counts on the oral flora. This suggests the preparation assists in establishing a localized hygienic state. The medicine is thus designed to manage general discomfort associated with the presence of microbial activity in the oropharynx.

What side effects are possible with Максиколд Лор?

Adverse Reactions and Safety Profile

The official safety profile for the active ingredient Hexetidine is established through regulatory classification and primarily involves reactions related to its topical action. Adverse effects are categorized by frequency and the body system affected, consistent with the international ICH/EMA frequency convention.

Classification System-Organ Class Examples of Documented Effects
Uncommon Nervous System, Local Disturbances in taste (dysgeusia), disturbances in smell (parosmia), and transient local burning or irritation.
Very Rare Immune System, Respiratory Severe systemic hypersensitivity reactions, including laryngeal edema and angioedema.
Not Known Gastrointestinal, Local Nausea, vomiting, local blister formation, ulceration, and transient tooth discoloration.

Serious adverse reactions documented in regulatory sources center on severe manifestations of systemic hypersensitivity, which require immediate attention. These are considered very rare.

Safety Constraints and Special Populations

Official labeling includes specific safety considerations related to patient groups and duration of use. Use in children under 3 years is contraindicated due to a specific regulatory-documented risk of laryngeal spasm associated with the solution's form. The product is strictly for topical use and must not be swallowed. Prolonged use is noted in official documents as potentially being associated with the occurrence of taste disturbances and transient tooth discoloration. The overall safety structure confirms that the risks are largely localized or related to rare allergic events, with low potential for systemic toxicity when used as intended.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Hexetidine overdose primarily addresses the potential risks associated with the liquid formulation’s excipient following accidental, massive ingestion. The documented clinical profile does not cite adverse effects of the active antiseptic component beyond those typically observed during normal use, which can include symptoms like nausea, vomiting, or dysphagia.

Severe Outcome and Urgent Action

The most significant theoretical outcome detailed in regulatory documents is acute alcoholic intoxication. This risk is linked to the high ethanol content of the liquid vehicle, particularly when a small child accidentally swallows the entire contents of a bottle. While the occurrence of this severe manifestation is classified as extremely unlikely, regulatory mandates require a specific emergency response.

When to Seek Immediate Medical Help

Immediate consultation with a doctor or Poison Control Center is required if a child has ingested the entire solution. The official management of overdose is defined as symptomatic treatment, which must be related to addressing the effects of alcoholic intoxication. Procedural intervention, such as the consideration of gastric lavage, may be warranted if the exposure is recent, typically within two hours of ingestion. All official guidance stresses that patients must seek professional medical attention under these circumstances.

Therapeutic Uses of Максиколд Лор

Main Uses and Therapeutic Benefits

Максиколд Лор is a local antiseptic preparation that plays a role in managing symptoms related to inflammatory or irritative states in the mouth and throat. It is generally considered relevant when supportive symptom management is appropriate, as it is relevant in contexts involving heightened systemic burden and localized discomfort.

The medicine is commonly used across conditions presenting with acute episodes and is applied across domains where additional symptomatic support is needed. This includes addressing symptoms related to infectious-inflammatory conditions such as pharyngitis, tonsillitis, stomatitis, gingivitis, and oral candidiasis. The preparation is also relevant in contexts involving heightened systemic burden and localized discomfort, such as following dental procedures.

“The preparation may assist with providing local symptomatic support that helps ease the overall burden of acute or recurrent discomfort in the oropharyngeal area.”

It is relevant for easing local symptoms related to inflammatory or irritative states, which may contribute to easing the overall symptom load. This supportive action contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability when symptoms are more noticeable, supporting patients during difficult episodes.


Quick Fact: Relief for Local Irritation
The preparation is relevant for easing symptoms that cluster into patterns of local inflammation and pain, helping patients cope more steadily with temporary functional strain.

Regulatory References

  1. Health Products Regulatory Authority (HPRA) guidance

Eligibility and Restrictions for Use

Максиколд Лор, which contains the antiseptic Hexetidine as its primary active ingredient in the spray form, is generally indicated for the local treatment of infectious and inflammatory diseases of the mouth and throat.

Who Can Use It

  • Adults for symptomatic relief and treatment of conditions like pharyngitis, tonsillitis, laryngitis, stomatitis, and gingivitis.
  • Children are typically permitted to use the spray form of the medication starting from 3 years of age and older. Specific formulations, such as the lozenges (containing Flurbiprofen and Cetylpyridinium Chloride), are generally restricted to those 18 years of age and older.

Who Should Not Use It (Contraindications)

Individuals should avoid using Hexetidine-containing Максиколд Лор if they have:

  • A known hypersensitivity or allergy to Hexetidine or any of the product's excipients.
  • Atrophic pharyngitis (a severe, dry form of chronic pharyngitis).
  • An age below 3 years for the spray formulation due to the risk of bronchospasm or difficulty coordinating the spray and inhalation.
  • In cases of deep or extensive lesions in the oral cavity that require alternative treatment.

Special consideration is also warranted for use during pregnancy and breastfeeding, where it should only be used if the potential benefit justifies the potential risk, and only under medical supervision.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official regulatory documentation for Максиколд Лор (Hexetidine) specifies that data on interactions with other medicinal products are not available or absent from the established product profile. This absence of documented interaction studies means that no formal warnings or constraints regarding co-administration with specific drugs are defined in the regulatory labeling.

Since Hexetidine is minimally absorbed systemically when used as an oral solution, the risk of systemic pharmacokinetic interactions is generally considered low. However, the product profile includes several important non-drug interaction considerations that users should be aware of, as stated in the official materials.

Key Product Constraints and Components:

Constraint Category Official Statement in Regulatory Documents
Administration Timing Recommended for use after meals to ensure maximum adhesive contact of the active substance with the mucous membrane.
Ethanol Content The preparation contains ethanol (ethyl alcohol) in the formulation, and the total daily dose delivers a specified quantity of ethanol (e.g., 24-48 mg), which must be considered, particularly for individuals sensitive to alcohol or certain populations.
Drug Interactions Data on medicinal product interaction is absent.

No officially defined interaction severity classifications (such as contraindicated or high-risk) exist, as the formal interaction profile is based on a lack of available data on systemic interactions. Any use of this product should adhere strictly to the information presented in the official label.

Mechanism of Action

Direct Assault on Microbial Cell Integrity

The primary mechanism of action is the cytotoxicity of the active ingredient, Hexetidine, directed against microbial pathogens (bacteria and fungi). Hexetidine is a cationic antiseptic that employs an electrostatic interaction to bind specifically to the negatively charged surface of the microbial cell envelope. This binding rapidly disrupts the cell's outer structural integrity, a process known as membrane permeabilization. This mechanistic domain results in the immediate structural breakdown and leakage of low molecular weight cellular contents.

Metabolic Shutdown and Pathogen Load Reduction

Following membrane disruption, the drug penetrates the cell and acts as a non-specific inhibitor, interfering with the pathogen's metabolic enzyme systems, such as those responsible for energy production. This dual action—structural damage combined with metabolic blockade—leads to cellular damage and cessation of function, resulting in pathogen death (bactericidal and fungicidal effect). The mechanistic consequence of this action is a localized decrease in the population of susceptible microorganisms on the oropharyngeal mucosa.

Sustained Surface Activity (Substantivity)

Due to its cationic charge, the active ingredient adheres to the mucosal lining of the throat and mouth, a property termed substantivity. This allows the molecule to remain present on the surface for a period of time, thus extending the duration of the local anti-microbial mechanism after application. This mechanism is confined strictly to the surface and does not rely on systemic absorption.

Dosage and Administration Information

How to Use Максиколд Лор

The usage of Максиколд Лор, which contains hexetidine, is a topical oromucosal application to the surfaces of the mouth and throat. The instructions emphasize that the preparation must not be swallowed and must be expelled after the application procedure.

Official Administration Guidelines

Feature Official Instruction
Route of Administration Topical oromucosal use only.
Standard Dosing Use of 10 to 20 milliliters (mL) of the 0.1% undiluted solution per application.
Frequency Two to three times per day, with a maximum limit of three daily administrations.
Duration Constraint Short-term use only, limited to a maximum course of 10 consecutive days.

The solution is typically administered in its undiluted form via gargling or rinsing the affected areas. Following application, the solution is spat out.

Population-Specific Rules

The preparation is intended for use by adults and adolescents. Use in children is subject to age restrictions, varying by regional labeling (e.g., 6 years or 12 years and over). When administered to children, the procedure must be conducted under the supervision of an adult to ensure proper application technique and prevent accidental ingestion. Adherence to these guidelines, including the specific dosing volume and frequency, structures the protocol for using this antiseptic agent.

Recent Clinical Evidence

Research evidence / Overview of studies for Максиколд Лор

Research examined the active component in Максиколд Лор, Hexetidine, in studies exploring localized antiseptic action in several clinical scenarios. The available research generally focuses on the short-term use of the product, examining how it performs in conditions where symptoms may vary in intensity. Studies monitored changes over defined time intervals to understand symptom patterns in the observed populations.


Evidence for Use in Acute Sore Throat and Tonsillar Discomfort

Evidence for acute pharyngitis and tonsillitis is derived from short-term Randomized Controlled Trials (RCTs) involving adults. These studies monitored measurements related to physical discomfort, such as pain, and visual changes related to measurements of inflammation in the throat. Studies reported how symptoms evolved in the observed populations. The evidence quality for this area of study is classified as Moderate. Follow-up durations were limited, meaning the body of dedicated, large-scale studies is not fully established.

Evidence for Localized Oral Health and Inflammation

Research explored the compound in conditions characterized by oral inflammation, such as gingivitis, and examined its influence on the microbial load in the mouth. This body of research includes Systematic Reviews and controlled clinical studies monitoring standardized oral health indices and measurements of bacterial and fungal counts.

Evidence in Fungal-Related Conditions

A smaller number of specific clinical in vivo studies explored the compound in research examining fungal organisms (e.g., Candida albicans). This evidence is limited and has focused on a narrow population, such as adults with denture issues.


Research Gaps and Areas of Uncertainty

The majority of research scenarios were designed for short-term changes; long-term effects are not fully established. Studies primarily evaluated adult populations, and data for children, older adults, or pregnant individuals remain insufficient. The evidence quality varies across studies, with sample sizes often being modest, contributing to a lower certainty level for certain findings.

Key Studies & References

  1. WHO ATC Classification System: Hexetidine (A01AB12)

Frequently Asked Questions (FAQ)

Common questions about Максиколд Лор (FAQ)


Q: Can taking Максиколд Лор cause drowsiness?

Drowsiness (somnolence) is not listed as a documented side effect in the official safety profile for the active ingredient, Hexetidine. Official regulatory information indicates that the product has no or negligible influence on the ability to drive or operate machinery.


Q: How quickly does Максиколд Лор usually start to work?

Regulatory assessments indicate the active substance works rapidly against microorganisms through its antiseptic mechanism on the mucosal surface. Due to a property known as substantivity, the active substance is designed to adhere to the oral tissues for a sustained period, extending its local anti-microbial action.


Q: Is it normal to feel a tingling sensation after using Максиколд Лор?

Official safety documents classify transient local irritation or a burning sensation as possible but uncommon adverse effects. It is possible that users may perceive these local effects as a tingling sensation.


Q: Can I use Максиколд Лор if I am pregnant or breastfeeding?

Formal studies on the use of the product during pregnancy and breastfeeding in humans are generally absent. Regulatory documents indicate that due to minimal systemic absorption, the risk is considered unlikely. However, use during pregnancy or breastfeeding is generally reserved for situations where a qualified professional determines the potential benefit justifies the potential risk.


Q: What happens if someone accidentally swallows a large amount of the spray?

The product is for external topical use only and must not be swallowed. While the active substance at therapeutic strength is considered unlikely to be toxic, a large, accidental ingestion of the product is classified as harmful and requires immediate medical attention.


Q: Can I use Максиколд Лор if I have diabetes?

The official product documentation should be checked for a full list of excipients, as this formulation contains ethanol (ethyl alcohol). The presence of ethanol and other excipients in the preparation is a factor that patients with diabetes should be aware of.


Q: Can I use Максиколд Лор while taking antibiotics?

Official regulatory labels state that data on interactions with other medicinal products, including antibiotics, are generally absent from the product profile. Since the active substance, Hexetidine, is minimally absorbed systemically when used correctly, the risk of systemic drug interaction is considered low.


Q: Does Максиколд Лор interact with common pain relievers like paracetamol?

Official product information notes that data regarding interactions with other medicinal products, such as paracetamol, are generally absent. Given the very minimal systemic absorption of Hexetidine, the potential for systemic interaction is considered low.


Q: Is it okay to drink water immediately after using Максиколд Лор?

The active substance is designed to adhere to the mucosal lining of the throat and mouth to prolong its action (substantivity). While specific instructions to avoid rinsing are not universally explicit, the recommended use after meals is intended to maximize this contact, suggesting that immediately rinsing the area with water could interfere with the duration of the substance's adherence to the tissue.


Q: Can Максиколд Лор be taken with food?

Official administration instructions recommend using the preparation after meals. This specific timing is intended to ensure maximum adhesive contact of the active substance with the mucous membrane of the oral cavity and pharynx.


Q: Is Максиколд Лор the same as other sore throat sprays?

Максиколд Лор contains the specific active ingredient Hexetidine. It is classified as an antiseptic (a type of anti-microbial agent) for local oral treatment, which distinguishes it from products that contain different active substances, such as local anesthetics or non-steroidal anti-inflammatory drugs (NSAIDs).


Q: Is there a different Максиколд Лор for children?

The official product range may include different formulations of Максиколд Лор, such as lozenges or oral solutions, which may be intended for different age groups or contain different active ingredients. For example, lozenges are typically reserved for adults (18+), while the spray formulation can be used by children (3+) under supervision.


Q: Are there any known interactions between Максиколд Лор and alcohol?

The product formulation contains ethanol (ethyl alcohol) as an inactive component (excipient). However, due to the minimal systemic absorption of the product, the official regulatory label does not document systemic interaction with consumed alcoholic beverages.


Q: Does Максиколд Лор contain sugar or artificial sweeteners?

The full list of inactive ingredients (excipients) for the specific formulation is detailed in the official product information. This document specifies all components, including any sugar, artificial sweeteners, or colorings. This information is relevant for patients, such as those with diabetes.


Q: Can I use Максиколд Лор if I have liver or kidney problems?

Official product profiles generally lack specific pharmacokinetic data in patients with liver or kidney impairment. However, given the minimal systemic absorption of the active ingredient, Hexetidine, it is considered unlikely to require dosage adjustment or specific contraindication based on these conditions.


Q: Does Максиколд Лор affect my ability to drive or operate machinery?

Official regulatory information specifies that the product has no or negligible influence on the ability to drive or operate heavy machinery, which is consistent with its topical administration and minimal systemic absorption.


Q: Is there a specific way to apply the spray to maximize its effect?

Official instructions specify that the product is for topical application to the oral mucosa. Its intended effectiveness is achieved by ensuring the affected area is coated. It is specifically recommended for use after meals to maximize its adhesion to the mucous membrane.


Q: Can Максиколд Лор be used for general throat irritation that is not due to an infection?

The medicine’s official indication is for the local antiseptic treatment of infectious and inflammatory diseases of the mouth and throat. Its primary function is to provide a localized anti-microbial effect on tissue surfaces.


Q: Is the numbing effect of the spray a sign that the medicine is working?

The primary mechanism of action for the active ingredient is its antiseptic effect—its ability to reduce local microbial populations. While the product may cause localized sensations, the sensation of numbness or reduced feeling is not the official measure of the drug’s antiseptic action.


Q: Is the research on Максиколд Лор conducted internationally?

The official regulatory assessment of the product relies on a body of scientific evidence. This evidence includes published data and studies on the active ingredient, Hexetidine, which are often subject to international standards and reviews.


Q: Are there any reports of allergic reactions to the coloring agent in Максиколд Лор?

The medicine is contraindicated for individuals with a known hypersensitivity or allergy to the active ingredient, Hexetidine, or any of its excipients. Specific allergic reactions to a coloring agent are not typically detailed in the main regulatory profile, but the general safety profile states contraindications for allergy to the active ingredient or any of its excipients.


Q: Why is it recommended to avoid inhaling the spray?

Official warnings specify that the product is for external topical use and must not be swallowed or inhaled. This warning is particularly emphasized for younger children (under 3 years) due to a regulatory-documented risk of laryngeal spasm (a sudden closure of the voice box).


Q: Does Максиколд Лор help to clear mucus in the throat?

The primary function of the active ingredient is its antiseptic (anti-microbial) action. Official indications confirm the medicine is for the local treatment of infectious and inflammatory conditions; it is not indicated as a mucolytic or expectorant agent (a medicine that helps clear mucus).


Q: Can I use Максиколд Лор if I wear dentures or have dental work?

Official safety data mentions that transient tooth discoloration has been noted with prolonged use of the product. Research has explored the active compound's localized anti-microbial influence in relation to overall oral health, which includes conditions relevant to dentures or dental work.


Q: Is there a risk of throat irritation or burning sensation from using the spray?

Official safety data lists transient local burning or irritation as an uncommon adverse effect associated with the use of the product. This means that, while possible, this effect is documented to occur in less than 1 in 100 people.


Q: Are there specific food or beverage types to avoid while using Максиколд Лор?

Official administration guidelines recommend using the preparation after meals. However, specific food or beverage types to avoid are not documented as formal contraindications in the official product label.


Q: How should the spray nozzle be cleaned after use?

Official instructions specify that the applicator must be removed after use, rinsed with running water, and dried at room temperature. It should then be stored with the product in its original packaging.


Q: Can Максиколд Лор be used to help with coughing?

The medicine’s official indication is for the local antiseptic treatment of infectious and inflammatory conditions in the mouth and throat. It is not indicated as a cough suppressant or for the treatment of coughing.


Q: Is it possible for Максиколд Лор to cause a dry mouth?

Official safety data reports that dry mouth (xerostomia) has been noted as a potential adverse effect. However, its frequency is currently classified as 'not known' in regulatory documentation.


Q: What distinguishes Максиколд Лор from similar products in terms of active ingredients?

Максиколд Лор is officially defined by its active ingredient, Hexetidine, which is a specific synthetic anti-microbial agent. This core component distinguishes it from similar products that rely on different active ingredients, such as other antiseptics, anesthetics, or anti-inflammatory agents.


Q: What kind of side effects are common with Максиколд Лор?

Documented effects that are classified as uncommon (occurring in less than 1 in 100 people) include disturbances in taste or smell, and transient local irritation or a burning sensation.

How should Максиколд Лор be stored and disposed of?

Storage Requirements

Максиколд Лор must be stored at a temperature not exceeding 25 C to maintain product stability. Both the lozenges and the spray must be kept in their original packaging and stored in a location inaccessible to children. The spray formulation has a specific restriction: it must not be frozen.

Handling and Disposal

For the spray, the applicator must be removed after use, rinsed with running water, dried at room temperature, and stored with the product in the packaging. After the expiration date, the medicine must not be used. The spray is contained in a pressurized canister, and official instructions strictly prohibit the canister from being burned, punctured, or opened, even when empty, as a safety precaution related to its contents.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Максиколд Лор found in:

A-Z Index: